Flexible, Cost-effective Testing Options That Deliver Timely Results

Gastrointestinal Infection Portfolio


From targeted assays for C. difficile to broad disease state panels covering community-acquired and persistent diarrhea pathogens, clinical labs need flexibility and scalability in their GI assays to deliver optimal results to physicians for patient care, antimicrobial stewardship, and infection control.


That’s why Luminex offers targeted diagnostic options for nosocomial diarrhea and syndromic panels for community acquired/traveler’s diarrhea that align with recommended guidelines. These molecular solutions offer improved clinical outcomes when compared to traditional culture methods. In addition, the flexibility empowers clinical laboratories to improve efficiency by reducing turnaround time, consolidating sample testing, and reducing opportunities for human error. Overall, these solutions can help clinical labs generate actionable results while reducing costs.


Our gastrointestinal testing platforms are scalable to fit low-volume labs, high-capacity reference labs, and everything in between.


Learn more about our gastrointestinal infection testing options:




Which Test is Right for You?
Category Targeted
(Nosocomial Diarrhea)
(Community-Acquired / Persistent Diarrhea)
Assay ARIES® C. difficile Assay ARIES® Norovirus Assay VERIGENE® Enteric Pathogens Test xTAG® Gastrointestinal Pathogen Panel
Instruments ARIES® Systems ARIES® Systems VERIGENE® System MAGPIX®
Luminex® 100/200™
Pathogens 1 2 9 15
Turnaround Time
2 hours 2 hours 2 hours 5 hours
Hands-on Time
3 minutes
per sample
3 minutes
per sample
5 minutes
per sample
7 minutes
per 24 samples
Throughput Low – Medium Low – Medium Low – Medium High
  Learn More Learn More Learn More Learn More




Gastrointestinal Infection Resources:


Can Global Testing for C. difficile Carriers Help Prevent Healthcare-associated CDI?White Paper

Molecular Tests Provide a Better Alternative to Stool Culture for GI CasesWhite Paper

Rapid Diagnostics are Essential in the Battle Against Drug ResistanceOnline Article

Clinical Labs Streamline GI Testing with MDxMLO Online Article

Clinical Use of BI/NAP1/027 DetectionWhite Paper

Fecal Matters: Clinician and Laboratorian Perspective on Impact of Molecular GI Pathogen TestingWebinar

Molecular Testing for GI Pathogens: Cost-Effectiveness, Clinical Impact & Lab ImplementationWebinar

A GI Story: Jane & Tom’s Different Paths To a Proper Salmonella DiagnosisVideo

Fecal Matters: Molecular GI Testing-An Approach Based on Clinical GuidelinesWebinar

For In Vitro Diagnostic Use. Products are region specific and may not be approved in some countries/regions. Please contact Luminex at [email protected].com to obtain the appropriate product information for your country of residence.